NASDAQ:KTRA Kintara Therapeutics (KTRA) News Today $4.36 0.00 (0.00%) (As of 09/22/2023 ET) Add Compare Share Share Today's Range$4.17▼$4.4850-Day Range$3.30▼$4.9252-Week Range$2.70▼$15.50Volume13,227 shsAverage Volume15,714 shsMarket Capitalization$7.63 millionP/E RatioN/ADividend YieldN/APrice TargetN/A HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineKintara Therapeutics Non-GAAP EPS of -$9.27seekingalpha.com - September 19 at 10:27 PMKintara Therapeutics Announces Fiscal 2023 Year Financial Results and Provides Corporate Updatefinance.yahoo.com - September 18 at 7:30 PMKTRA - Kintara Therapeutics, Inc.uk.finance.yahoo.com - September 14 at 8:06 PMKintara Therapeutics (NASDAQ:KTRA) Shares Down 3.1% americanbankingnews.com - September 14 at 1:49 AMKintara Therapeutics to Present at the 2023 European Association for Neuro-Oncology Annual Meetingfinance.yahoo.com - September 5 at 10:32 AMKintara Therapeutics to Host Virtual KOL Event on VAL-083, A Potential First-in-Class Small Molecule Chemotherapeutic for Glioblastoma, on August 21, 2023finance.yahoo.com - August 17 at 9:26 PMKintara Therapeutics to Present at the Emerging Growth Conferencefinance.yahoo.com - August 9 at 8:24 AMPresenting on the Emerging Growth Conference on August 9 & 10 Register Nowfinance.yahoo.com - August 8 at 7:19 AMBenzinga's Top Ratings Upgrades, Downgrades For July 14, 2023msn.com - July 14 at 12:49 PMKintara (KTRA) Rises 41% on $2M Grant for Breast Cancer Therapyfinance.yahoo.com - June 30 at 1:27 PMKintara Therapeutics Stock Is Trading Higher: What's Driving The Action?benzinga.com - June 29 at 10:02 AMKintara Therapeutics Awarded $2.0 Million National Institutes of Health SBIR Grant to Support the Clinical Development of REM-001finance.yahoo.com - June 28 at 6:15 PMKintara Therapeutics to Participate in the Maxim Group Virtual Healthcare Conferencefinance.yahoo.com - June 16 at 10:38 AMKintara Therapeutics to Commemorate National Brain Tumor Awareness Month with Ringing the Bell at Nasdaq Closing Along with Global Coalition for Adaptive Research and the National Brain Tumor Societyfinance.yahoo.com - May 19 at 4:18 PMRecap: Kintara Therapeutics Q3 Earningsmsn.com - May 12 at 5:52 AMKintara Therapeutics Announces Fiscal 2023 Third Quarter Financial Results and Provides Corporate Updatefinance.yahoo.com - May 11 at 8:45 AMKintara Therapeutics to Present at the Sidoti Micro-Cap Virtual Conferencefinance.yahoo.com - May 8 at 9:06 AMKintara Therapeutics to Present at the Aegis Capital Virtual Conferencefinance.yahoo.com - May 1 at 10:47 AMKintara Therapeutics Announces Data Presentation at the 2023 American Association for Cancer Research Annual Meetingfinance.yahoo.com - April 14 at 1:15 PMThese 4 Biotech Stocks Just Got ‘Fast Track’ Designation Greenlightsca.finance.yahoo.com - March 17 at 2:38 PMKintara Therapeutics to Present Two Posters at the 2023 American Association for Cancer Research Annual Meetingfinance.yahoo.com - March 15 at 9:47 AMKintara Therapeutics Scheduled to Present at Two Conferences the Week of March 13, 2023finance.yahoo.com - March 10 at 8:52 AMKintara Therapeutics Announces Fiscal 2023 Second Quarter Financial Results and Provides Corporate Updatefinance.yahoo.com - February 14 at 5:11 PMKintara Therapeutics to Present at the 2023 BIO CEO & Investor Conferencefinance.yahoo.com - January 30 at 9:06 AMKintara Therapeutics to Present at the Biotech Showcase Conference on January 10, 2023finance.yahoo.com - January 9 at 9:32 AMIs Kintara Therapeutics A Hidden Gem?marketbeat.com - December 30 at 1:00 AMKintara Therapeutics Shares Rise 29% After Orphan Drug Designation for VAL-083marketwatch.com - December 15 at 3:02 PMWhy Kintara Therapeutics Stock Is Seeing Blue Skies Thursdaymsn.com - December 15 at 3:02 PMKintara Therapeutics Receives Orphan Drug Designation for VAL-083 for Treatment of Diffuse Intrinsic Pontine Glioma (DIPG)finance.yahoo.com - December 15 at 10:02 AM10 Pump and Dump Stocks Hedge Funds Likefinance.yahoo.com - December 2 at 10:24 AMLatest Set of FDA Fast Track Designations Causing Optimism in Biotech Sectorbaystreet.ca - December 1 at 12:38 PMWave of FDA Fast Track Designations Sparks Renewed Interest in Biotech Sector That's Heating Upbenzinga.com - December 1 at 12:38 PMKintara Therapeutics to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022finance.yahoo.com - December 1 at 12:38 PMAnalyzing Kintara Therapeutics's Short Interestmsn.com - November 30 at 11:28 AMKintara Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirementfinance.yahoo.com - November 30 at 10:32 AMmarketbeat.com - November 30 at 9:34 AMKintara: FDA Grants Fast Track Designation To REM-001 Therapy - Quick Factsmarkets.businessinsider.com - November 28 at 4:52 PMKintara Therapeutics Rallies As Its REM-001 To Treat Breast Cancer Gets Fast Track Designationmarkets.businessinsider.com - November 28 at 4:52 PMWhat's Going On With Kintara Therapeutics Stock?msn.com - November 28 at 4:52 PMKintara adds 26% on FDA Fast Track status for breast cancer candidateseekingalpha.com - November 28 at 4:52 PMKintara Therapeutics Shares Rally Premarket on FDA Fast-Track Designation >KTRAmarketwatch.com - November 28 at 4:52 PMKintara Therapeutics Granted Fast Track Designation from FDA for REM-001 for Cutaneous Metastatic Breast Cancerfinance.yahoo.com - November 28 at 4:52 PMKintara Therapeutics Presents Three Posters at the 2022 Society for Neuro-Oncology Annual Meetingfinance.yahoo.com - November 18 at 12:59 PMKintara Announces One-for-Fifty Reverse Stock Splitfinance.yahoo.com - November 11 at 9:55 AMKintara Therapeutics Announces Fiscal 2023 First Quarter Financial Results and Provides Corporate Updatefinance.yahoo.com - November 9 at 6:59 PMKintara Decides To Pause REM-001 Program - Quick Factsmarkets.businessinsider.com - October 19 at 12:32 PMKintara Therapeutics Pauses REM-001 Program to Conserve Funds to Support VAL-083 International Registrational Studyfinance.yahoo.com - October 19 at 12:32 PMKintara Therapeutics Increuters.com - October 16 at 10:48 AMKintara Therapeutics Announces Fiscal 2022 Financial Results and Provides Corporate Updatefinance.yahoo.com - September 27 at 9:12 AMKTRA Kintara Therapeutics, Inc.seekingalpha.com - September 20 at 8:21 PM Get Kintara Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KTRA and its competitors with MarketBeat's FREE daily newsletter. Email Address KTRA Media Mentions By Week KTRA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KTRA News Sentiment▼-0.800.53▲Average Medical News Sentiment KTRA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KTRA Articles This Week▼41▲KTRA Articles Average Week Get Kintara Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KTRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CRVO News Today ATHX News Today ALRN News Today TENX News Today ADMP News Today LEXX News Today BDRX News Today ATXI News Today DRUG News Today TPST News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:KTRA) was last updated on 9/23/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kintara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.